iShares Trust - iShares Biotechnology ETF
US ˙ NasdaqGM ˙ US4642875565

SecurityIBB / iShares Trust - iShares Biotechnology ETF
InstitutionTruist Financial Corp
Latest Disclosed Ownership666,343 shares
Latest Disclosed Value $ 112,512,008
Truist Financial Corp reports 3.79% increase in ownership of IBB / iShares Trust - iShares Biotechnology ETF

On April 27, 2026 - Truist Financial Corp filed a 13F-HR form disclosing ownership of 666,343 shares of iShares Trust - iShares Biotechnology ETF (US:IBB) valued at $112,512,016 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 642,023 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 3.79% during the quarter. The current value of the position is $111,612,452 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 666,343 24,320 3.79 112,512 3.84 0.1517
2026-02-02 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 642,023 614,582 2,239.65 108,354 2,635.52 0.1445
2025-11-03 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 27,441 -920 -3.24 3,962 10.43 0.0054
2025-07-18 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 28,361 -17,325 -37.92 3,588 -38.61 0.0053
2025-04-29 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 45,686 -7,201 -13.62 5,843 -16.43 0.0093
2025-01-31 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 52,887 14,770 38.75 6,992 26.00 0.0109
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 38,117 2,758 7.80 5,550 14.34 0.0087
2024-08-21 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 35,359 -36,325 -50.67 4,853 -50.66 0.0074
2024-05-13 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 71,684 44,682 165.48 9,836 168.16 0.0149
2024-02-02 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 27,002 -11,120 -29.17 3,668 -21.30 0.0058
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 38,122 -27,146 -41.59 4,662 -43.75 0.0078
2023-08-01 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 65,268 -14,648 -18.33 8,286 -19.72 0.0138
2023-05-05 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 79,916 5,709 7.69 10,322 5.94 0.0178
2023-02-17 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 74,207 1,035 1.41 9,743 13.84 0.0171
2022-10-26 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 73,172 12,890 21.38 8,558 20.69 0.0164
2022-07-22 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 60,282 -16,113 -21.09 7,091 -28.76 0.0130
2022-04-22 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 76,395 -24,503 -24.28 9,954 -35.36 0.0157
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 100,898 4,128 4.27 15,400 -1.57 0.0235
2021-11-05 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 96,770 2,494 2.65 15,645 1.41 0.0257
2021-08-16 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 94,276 5,308 5.97 15,428 15.18 0.0252
2021-05-17 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 88,968 197 0.22 13,395 -0.39 0.0233
2021-11-19 2020-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 88,771 8,766 10.96 13,448 24.13 0.0257
2021-02-18 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 88,771 8,766 13,448 0.0250
2021-11-05 2020-09-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 80,005 8,004 11.12 10,834 10.08 0.0237
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 80,005 8,004 10,834 0.0234
2021-11-16 2020-06-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 72,001 26,338 57.68 9,842 100.04 0.0221
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 72,001 26,338 9,842 0.0218
2021-11-05 2020-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 45,663 -23,994 -34.45 4,920 -41.39 0.0130
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45,663 -23,994 4,920 0.0128
2021-11-16 2019-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 69,657 69,657 8,394 0.0171
2020-02-14 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 69,657 69,657 8,394 0.0169
2019-01-22 2018-12-31 13F ISHARES NASDAQ EQUITY 464287556 0 -2,571 -100.00 0 -100.00
2018-10-17 2018-09-30 13F ISHARES NASDAQ EQUITY 464287556 2,571 508 24.62 314 38.94 0.0056
2018-07-26 2018-06-30 13F ISHARES NASDAQ EQUITY 464287556 2,063 2,063 226 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.